Iwaki (8095) Stock Overview

Astena Holdings Co., Ltd. manufactures and sells medicine-related products in Japan. The company's Fine Chemical division manufactures and sells active pharmaceutical ingredients and medical supplies for antipyretic, analgesic, anti-inflammatory, and vasoconstrictor areas. Its Medical division manufactures and sells semi-solid products, such as ointments, creams, and lotions, as well as solid products such as tablets and powders for the generic drug market; and manufactures a range of dosage forms, including injectable, solid, semi-solid, and liquid dosage forms on contract. The company's Health & Beauty Care, and Food division engages in the sale of over-the-counter drugs, food product materials, functional food product materials, and cosmetic ingredients; mail/Internet-ordered sales business; and OEM production of cosmetics. This division also offers 1,3-butylene glycol, natural plant extract, sodium acetylated hyaluronate, tea-tree oil, yeast extract, dehydrate potato, tomato powder, and meat extract powder. Its Industrial Chemicals division manufactures and sells surface finishing chemicals and other chemical products, such as products for PWBs, electronic devices, general platings, and semiconductors. The company was formerly known as Iwaki & Co., Ltd. and changed its name to Astena Holdings Co., Ltd. in June 2021. Astena Holdings Co., Ltd. was founded in 1914 and is based in Chuo, Japan.